Skip to main content

Day: February 1, 2022

Anti-Counterfeiting Packaging Market to Reach USD 189.9 Billion by 2026 | Global Anti-Counterfeiting Packaging Industry Share, Global Research and Forecast Report by Fortune Business Insights™

Companies covered in the anti-counterfeiting packaging market are MicroTagTemed Ltd., BrandWatch Technologies, AlpVision, SICPA HOLDING SA., Zebra Technologies Corporation, CCL Industries Inc., Impinj, Inc., Authentix., Avery Dennison Corporation, SML Group, 3M Company and many more players profiled. Pune, India, Feb. 01, 2022 (GLOBE NEWSWIRE) — According to the study by Fortune Business Insights™, the global anti-counterfeiting packaging market size is projected to reach USD 189.9 billion by 2026, exhibiting a CAGR of 7.8% during the forecast period. Rising menace of flagrant counterfeiting on e-commerce platforms is likely to emerge as the central growth driver for this market, E-commerce platforms have become a breeding ground for counterfeiters to sell fake products to unsuspecting customers.  A study conducted by a community...

Continue reading

Industrial Coatings Market to Hit 119.54 Billion by 2027 | Industrial Coatings Industry Size, Share, Demand, Outlook and Business Growth Report by Fortune Business Insights™

Companies covered in the global industrial coatings market are PPG Industries, Inc. (U.S.), The Sherwin-Williams Company (U.S.), Nippon Paint Holdings Co., Ltd. (Japan), Kansai Paint Co., Ltd. (Japan), RPM International Inc. (U.S.), BASF SE (Germany), PPG Asian Paints Pvt Ltd (India), Hempel A/S (Denmark), The Chemours Company FC, LLC. (U.S.), Jotun A/S (Norway), and other key players Pune, India, Feb. 01, 2022 (GLOBE NEWSWIRE) — According to Fortune Business Insights, the global industrial coatings market size report further states that the industrial coatings market size was USD 86.81 billion in 2019 and is projected to reach USD 119.54 billion by 2027, exhibiting a CAGR of 4.4% during the forecast period. The global industrial coatings market is set to impetus from the increasing focus of manufacturers towards developing greener...

Continue reading

Active Pharmaceutical Ingredient Market Size [2022-2028] | to Reach USD 272.44 Billion, with 6.6% CAGR

Key Companies in the Active Pharmaceutical Ingredient Market Research Report Are Aurobindo Pharma, Teva Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Mylan N.V., AbbVie Inc., Sun Pharmaceutical Industries Ltd., Abbott, Biocon, Cipla Inc., Amgen Inc. and other key market players. Pune, India, Feb. 01, 2022 (GLOBE NEWSWIRE) — The global active pharmaceutical ingredient market size was USD 159.35 billion in 2020. The market is projected to grow from USD 174.17 billion in 2021 to USD 272.44 billion in 2028 at a CAGR of 6.6% in the 2021-2028 period. This information is provided by Fortune Business Insights™, in its report, titled, “Active Pharmaceutical Ingredient Market, 2021-2028.” According to our expert analysts, the increasing prevalence of chronic diseases and the rising demand for modified medicine, coupled with...

Continue reading

Biofrontera Inc. provides Update on Patient Recruitment for Phase III Study for the Treatment of sBCC with Ameluz®-PDT

WOBURN, Mass., Feb. 01, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI) (the “Company”), a biopharmaceutical company specializing in the commercialization of dermatological products, is pleased to provide an update on the patient recruitment for the phase III clinical study for the treatment of superficial basal cell carcinoma (sBCC) with Ameluz® photodynamic therapy (Ameluz®-PDT) in combination with the BF-RhodoLED® lamp in the U.S. To date, 70% of the planned 186 patients have been enrolled in the study. Patient recruitment for this study has been ongoing since 2018 with completion of patient recruitment anticipated by the end of 2022. “Due to a demanding study protocol mandated by the FDA, the recruitment process has been taking a considerable amount of time and was additionally slowed down by the Covid pandemic, but...

Continue reading

Freddie Mac Announces Tender Offer for Any and All of Certain STACR Debt Notes

MCLEAN, Va., Feb. 01, 2022 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) today announced that it has commenced a fixed-price cash tender offer (the “Offer”) for the purchase of any and all of the STACR® (Structured Agency Credit Risk) Debt Notes listed below (the “Notes”) beginning Tuesday, Feb. 1, 2022. Freddie Mac has engaged BofA Securities, Inc. and Barclays Capital Inc. as lead dealer managers (the “Lead Dealer Managers”) and CastleOak Securities, L.P. as co-dealer manager (the “Co-Dealer Manager” and, collectively with the Lead Dealer Managers, the “Dealer Managers”) for the offer. Freddie Mac is offering to purchase any and all of the Notes listed in the table below. The applicable Total Consideration to be paid by Freddie Mac to holders that tender Notes accepted for purchase pursuant to the Offer will be calculated based...

Continue reading

Healixa Appoints Richard Alloway II to its Advisory Board

Manhattan, NY, Feb. 01, 2022 (GLOBE NEWSWIRE) — Healixa, Inc. (OTC Pink: EMOR) (“Healixa”, or the “Company”), a technology company focusing on building and acquiring innovative and disruptive technologies in the health-tech, clean water, and green-tech industries, today announces that Richard Alloway II will join its Advisory Board, effective immediately, demonstrating the Company’s commitment to supporting truly sustainable communities through ethically engineered technologies. Richard Alloway II is an American politician and lawyer. He is a former Republican member of the Pennsylvania State Senate. Mr. Alloway was first elected in 2008 to serve as the State Senator for the 33rd District, and was subsequently re-elected in 2012 and 2016. Mr. Alloway became the Republican Caucus secretary in 2014, and was...

Continue reading

Cannabix Technologies Develops Version 4.0 of THC Breath Analyzer Device

Cannabix is developing Marijuana Breathalyzer devices to give law enforcement and employers a tool to enhance public safetyCannabix Technologies Inc.Cannabix Technologies Inc. THC Breath Analyzer Ver 4.0Cannabix Technologies Inc.Cannabix Technologies Inc. THC Breath Analyzer Ver 4.0VANCOUVER, British Columbia, Feb. 01, 2022 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of marijuana breathalyzer devices for law enforcement and the workplace is pleased to report that it has assembled its version 4.0 THC Breath Analyzer (“THCBA”) prototype and portable system for field use. This updated device incorporates planned design changes and feedback from beta-test users. Several components such as the device’s internal sampling chambers,...

Continue reading

Diana Shipping Inc. Announces Time Charter Contract for m/v Los Angeles With Koch

ATHENS, Greece, Feb. 01, 2022 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Koch Shipping Pte. Ltd., Singapore, for one of its Newcastlemax dry bulk vessels, the m/v Los Angeles. The gross charter rate is US$26,250 per day, minus a 5% commission paid to third parties, for a period until minimum January 15, 2023 up to maximum March 15, 2023. The charter commenced retroactively as of January 30, 2022. The m/v Los Angeles was chartered, as previously announced, to Engelhart CTP Freight (Switzerland) SA, at a gross charter rate of US$14,250 per day, minus a 5% commission paid to third parties. The “Los Angeles” is a 206,104...

Continue reading

Robotic Assistance Devices Signs SekurCorp as New Dealer and Receives AVA Order

Artificial Intelligence Technology Solutions, Inc.RAD’s AVA 3.0 shown with STAN, AVA’s proprietary stanchion. RAD is a wholly owned subsidiary of Artificial Intelligence Technology Solutions, Inc., (AITX)Detroit, Michigan, Feb. 01, 2022 (GLOBE NEWSWIRE) — Artificial Intelligence Technology Solutions, Inc., (OTCPK:AITX), today announced that its wholly owned subsidiary Robotic Assistance Devices, Inc. (RAD) has signed SekurCorp as an authorized dealer, and has received an AVA order from this new dealer. SekurCorp is a regional security services provider with offices located in Montreal, Quebec Canada and St. Johnsbury, Vermont. “We just love signing new channel partners that can help RAD penetrate new markets and opportunities,” said Mark Folmer, President of RAD. “The addition of a forward-looking...

Continue reading

Quotient Limited Provides MosaiQ Regulatory & Commercial Update

The company remains in contact with the European Notified Body and continues to anticipate approval in Q1 CY22 First time attendance to Arab Health and Medlab Middle East 2022 in Dubai Generated traction on MosaiQ solution from potential distributorsJERSEY, Channel Islands, Feb. 01, 2022 (GLOBE NEWSWIRE) — Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company headquartered in Eysins, Switzerland, today announced its attendance for the first time to the Arab Health and Medlab Middle East Conference in Dubai, United Arab Emirates. Medlab Middle East 2022, a co-located event with Arab Health, hosted its 21st edition of the congress, the region’s only multi-disciplinary congress for the healthcare and laboratory industries. Senior leaders attended the conference last week, to further advance the company’s strategic...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.